Unknown

Dataset Information

0

Integrin-linked kinase as a novel molecular switch of the IL-6-NF-?B signaling loop in breast cancer.


ABSTRACT: Substantial evidence has clearly demonstrated the role of the IL-6-NF-?B signaling loop in promoting aggressive phenotypes in breast cancer. However, the exact mechanism by which this inflammatory loop is regulated remains to be defined. Here, we report that integrin-linked kinase (ILK) acts as a molecular switch for this feedback loop. Specifically, we show that IL-6 induces ILK expression via E2F1 upregulation, which, in turn, activates NF-?B signaling to facilitate IL-6 production. shRNA-mediated knockdown or pharmacological inhibition of ILK disrupted this IL-6-NF-?B signaling loop, and blocked IL-6-induced cancer stem cells in vitro and estrogen-independent tumor growth in vivo Together, these findings establish ILK as an intermediary effector of the IL-6-NF-?B feedback loop and a promising therapeutic target for breast cancer.

SUBMITTER: Hsu EC 

PROVIDER: S-EPMC5006214 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2917033 | biostudies-literature
| S-EPMC5126188 | biostudies-other
| S-EPMC9621571 | biostudies-literature
| S-EPMC3147799 | biostudies-literature
| S-EPMC6868140 | biostudies-literature
| S-EPMC5576939 | biostudies-literature
2012-01-18 | E-GEOD-35129 | biostudies-arrayexpress
| S-EPMC6248369 | biostudies-literature
| S-EPMC4719004 | biostudies-literature
| S-EPMC10057834 | biostudies-literature